Marjut Natynki
Oulu, 90220, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
PALB2 mutations increase oncogenic properties of breast epithelial cells by enhancing JAM3 and PARVB expression.
Journal: Biochemical and biophysical research communications
Published: February 09, 2025
PALB2-mutated human mammary cells display a broad spectrum of morphological and functional abnormalities induced by increased TGFβ signaling.
Journal: Cellular and molecular life sciences : CMLS
Published: June 02, 2023
PHD2 deletion in endothelial or arterial smooth muscle cells reveals vascular cell type-specific responses in pulmonary hypertension and fibrosis.
Journal: Angiogenesis
Published: February 17, 2021
Angiopoietin-4-dependent venous maturation and fluid drainage in the peripheral retina.
Journal: eLife
Published: April 23, 2018
Development of Molecular Therapies for Venous Malformations.
Journal: Basic & clinical pharmacology & toxicology
Published: December 30, 2017
Blue Rubber Bleb Nevus (BRBN) Syndrome Is Caused by Somatic TEK (TIE2) Mutations.
Journal: The Journal of investigative dermatology
Published: April 29, 2016
Rapamycin improves TIE2-mutated venous malformation in murine model and human subjects.
Journal: The Journal of clinical investigation
Published: May 26, 2015
Common and specific effects of TIE2 mutations causing venous malformations.
Journal: Human molecular genetics
Published: February 19, 2015
Venous malformation-causative TIE2 mutations mediate an AKT-dependent decrease in PDGFB.
Journal: Human molecular genetics
Published: May 02, 2013
Ligand oligomerization state controls Tie2 receptor trafficking and angiopoietin-2-specific responses.
Journal: Journal of cell science
Published: February 24, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026